201Tl-99mTc subtraction scintigraphy in secondary hyperparathyroidism of chronic renal failure. 1988

W Moolenaar, and J M Heslinga, and J W Arndt, and C J vd Velde, and E K Pauwels, and R M Valentijn
Department of Nephrology and Internal Medicine, University Hospital, Leiden, The Netherlands.

In a group of 14 patients with chronic renal failure and secondary hyperparathyroidism, subtraction scintigraphy with 201Tl and 99mTc for parathyroid localisation was performed prior to subtotal parathyroidectomy. Fourteen of 38 (37%) enlarged hyperplastic glands found at first operation corresponded with the hot spots seen on the preoperative scans. Four of five (80%) found at a second operation had also been detected this way preoperatively. Postoperative scans were performed in nine patients. All hot foci seen on the preoperative scans had disappeared. In two patients new hot spots emerged correlating with known residual parathyroid tissue, and also in one patient with recurrent secondary hyperparathyroidism. We conclude that this diagnostic method is of limited value prior to the first neck exploration in secondary hyperparathyroidism of chronic renal failure. However it might be a useful method in the evaluation of patients with signs of persistent or recurrent hyperparathyroidism.

UI MeSH Term Description Entries
D006962 Hyperparathyroidism, Secondary Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY. Secondary Hyperparathyroidism,Hyperparathyroidisms, Secondary,Secondary Hyperparathyroidisms
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010280 Parathyroid Glands Two pairs of small oval-shaped glands located in the front and the base of the NECK and adjacent to the two lobes of THYROID GLAND. They secrete PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body. Gland, Parathyroid,Glands, Parathyroid,Parathyroid Gland
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013670 Sodium Pertechnetate Tc 99m A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints. Pertechnetate Sodium,Tc 99m-Pertechnetate,Technetium Tc 99m Pertechnetate,99Tc-Pertechnetate,99TcmO4,99mTcO4,Pertechnetate,Technetium Pertechnetate,Technetium Tc 99m O(4),Technetium-99mTc-pertechnetate,99Tc Pertechnetate,99m-Pertechnetate, Tc,Pertechnetate, Technetium,Sodium, Pertechnetate,Tc 99m Pertechnetate,Technetium 99mTc pertechnetate

Related Publications

W Moolenaar, and J M Heslinga, and J W Arndt, and C J vd Velde, and E K Pauwels, and R M Valentijn
October 1990, Acta endocrinologica,
W Moolenaar, and J M Heslinga, and J W Arndt, and C J vd Velde, and E K Pauwels, and R M Valentijn
June 1994, European journal of nuclear medicine,
W Moolenaar, and J M Heslinga, and J W Arndt, and C J vd Velde, and E K Pauwels, and R M Valentijn
January 1987, The Japanese journal of surgery,
W Moolenaar, and J M Heslinga, and J W Arndt, and C J vd Velde, and E K Pauwels, and R M Valentijn
October 1997, Kaku igaku. The Japanese journal of nuclear medicine,
W Moolenaar, and J M Heslinga, and J W Arndt, and C J vd Velde, and E K Pauwels, and R M Valentijn
January 1983, Scandinavian journal of urology and nephrology. Supplementum,
W Moolenaar, and J M Heslinga, and J W Arndt, and C J vd Velde, and E K Pauwels, and R M Valentijn
January 1981, Annals of clinical and laboratory science,
W Moolenaar, and J M Heslinga, and J W Arndt, and C J vd Velde, and E K Pauwels, and R M Valentijn
January 1972, Acta medica Iugoslavica,
W Moolenaar, and J M Heslinga, and J W Arndt, and C J vd Velde, and E K Pauwels, and R M Valentijn
December 2009, Vojnosanitetski pregled,
W Moolenaar, and J M Heslinga, and J W Arndt, and C J vd Velde, and E K Pauwels, and R M Valentijn
January 1980, La Ricerca in clinica e in laboratorio,
W Moolenaar, and J M Heslinga, and J W Arndt, and C J vd Velde, and E K Pauwels, and R M Valentijn
April 1995, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!